Join PharmaX Next 2026 in Madrid—where AI, biotech & digital health reshape pharma through innovation, networking & collaboration.
Event Overview
- Name: PharmaX Next Conference – International Conference on AI, Biotechnology, and Digital Transformation in Pharma
- Dates & Location: Scheduled for May 11-12, 2026, in Madrid, Spain pharmaxnext.com+1. (Some social posts earlier mentioned February dates, likely in error Instagram+1.)
What to Expect
- Thematic Focus: The conference spotlights how AI, biotechnology, and digital transformation are reshaping pharmaceutical sciences—from drug discovery and personalized medicine to clinical trials, supply chain efficiency, telemedicine, and sustainability pharmaxnext.com+1.
- Target Audience: It brings together a diverse group including:
- Researchers and academics
- Pharma & biotech companies
- Healthcare providers
- Tech vendors and digital health specialists
- Startups and entrepreneurs
- Policy makers, investors, NGOs, and analysts pharmaxnext.com.
Opportunities at the Conference
- Learning & Hands-On Experiences: Expect immersive sessions on AI-driven drug discovery, biotechnology breakthroughs, and digital health innovations pharmaxnext.comnextbusinessmedia.com.
- Networking & Collaboration: Offers rich opportunities to connect with global industry leaders, researchers, and investors.
- Presentations & Abstracts: Participants can submit abstracts and present their work—there are designated slots for showcasing research and innovation pharmaxnext.comnextbusinessmedia.com.
Organizer
- The event is organized by Next Business Media (NBM), an IT consultancy and events company based in Noida, India (with global operations) pharmaxnext.com.
Why Attend?
- Stay Ahead of Industry Trends: Positioned at the intersection of pharma, AI, and digital transformation.
- Cross-Sector Networking: Build partnerships across research, industry, investment, and policy.
- Influence & Visibility: Ideal for anyone seeking to contribute to the future of pharmaceutical innovation through presentations and meaningful dialogue.
